GBI Research Reports
GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.
Search GBI Research Reports
Latest Reports from GBI Research Reports
| |||||||||||||||||||||||
| Name | Date | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Digest: Glucose Monitoring Devices 2006 to 2020 - Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam) | May 31, 2014 | ||||||||||||||||||||||
| ...Glucose Monitoring Devices #### to #### Southeast Asia Taiwan. Indonesia. Malaysia. Singapore. Vietnam. Market Digest Table of Contents Page # GBIME###MS / Published MAY #### © GBI Research. This is a licensed product and is not to be photocopied # Table of... | |||||||||||||||||||||||
| Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation | May 30, 2014 | ||||||||||||||||||||||
| ...Psoriasis: Identifying and Commercializing First-in-Class Innovation GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published MAY #### Page # GBI Research Report Guidance This report is part of... | |||||||||||||||||||||||
| Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets | May 30, 2014 | ||||||||||||||||||||||
| ...Facial Aesthetics Market to #### Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIME####MR / Published May... | |||||||||||||||||||||||
| Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options | May 12, 2014 | ||||||||||||||||||||||
| ...Breast Cancer Therapeutics in Asia-Pacific Markets to #### Novel HER-# Positive Therapies Provide Diversified Treatment Options GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published MAY #### Page... | |||||||||||||||||||||||
| Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies | May 12, 2014 | ||||||||||||||||||||||
| ...Ovarian Cancer Therapeutics in Major Developed Markets to #### Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published MAY #### Page #... | |||||||||||||||||||||||
| Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers | Apr 30, 2014 | ||||||||||||||||||||||
| ...Insulin Delivery Devices Market to #### Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIME####MR / Published APR #### Page... | |||||||||||||||||||||||
| HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth | Apr 14, 2014 | ||||||||||||||||||||||
| ...HIV Therapeutics in Major Developed Markets to #### Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR... | |||||||||||||||||||||||
| Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant | Apr 14, 2014 | ||||||||||||||||||||||
| ...Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to #### Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR... | |||||||||||||||||||||||
| NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool | Mar 14, 2014 | ||||||||||||||||||||||
| ...NSCLC Therapeutics in Asia-Pacific Markets to #### Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR... | |||||||||||||||||||||||
| Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns | Mar 14, 2014 | ||||||||||||||||||||||
| ...Epilepsy Therapeutics in Major Developed Markets to #### New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR/ Published... | |||||||||||||||||||||||
| Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability | Mar 14, 2014 | ||||||||||||||||||||||
| ...Epilepsy Therapeutics in Asia Pacific Markets to #### Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published... | |||||||||||||||||||||||
| Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth | Feb 07, 2014 | ||||||||||||||||||||||
| ...Cystic Fibrosis Therapeutics in Major Developed Markets to #### CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published FEB ####... | |||||||||||||||||||||||
| Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth | Feb 07, 2014 | ||||||||||||||||||||||
| ...Systemic Psoriasis Therapeutics in Major Developed Markets to #### Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published FEB... | |||||||||||||||||||||||
| Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers | Feb 07, 2014 | ||||||||||||||||||||||
| ...Glucose Monitoring Device Market to #### Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIME####MR / Published FEB #### Page... | |||||||||||||||||||||||
| Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape | Jan 31, 2014 | ||||||||||||||||||||||
| ...Hepatitis C Therapeutics in Major Developed Markets to #### Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR... | |||||||||||||||||||||||
| Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need | Jan 31, 2014 | ||||||||||||||||||||||
| ...Gastrointestinal Therapeutics in Asia-Pacific Markets to #### Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JAN... | |||||||||||||||||||||||
| Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries | Jan 27, 2014 | ||||||||||||||||||||||
| ...Gastrointestinal Therapeutics in Major Developed Markets to #### New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JAN... | |||||||||||||||||||||||
| Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation | Dec 31, 2013 | ||||||||||||||||||||||
| ...Systemic Lupus Erythematosus: Identifying and Commercializing First-in-Class Innovation GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published DEC #### Page # GBI Research Report Guidance · This report is... | |||||||||||||||||||||||
| Traditional Wound Management Market to 2019 - Cost Sensitivity Spurs Adoption in Emerging Markets, as Uptake of Advanced Wound Management Products Limits Growth in Developed Economies | Dec 15, 2013 | ||||||||||||||||||||||
| ...Traditional Wound Management Market to #### Cost Sensitivity Spurs Adoption in Emerging Markets, as Uptake of Advanced Wound Management Products Limits Growth in Developed Economies GBI Research Report Guidance © GBI Research. This is a licensed product and is not to... | |||||||||||||||||||||||
| Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth | Dec 15, 2013 | ||||||||||||||||||||||
| ...Monoclonal Antibodies Market in Gastric and Esophageal Cancers to #### Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published... | |||||||||||||||||||||||
